2026 ICD-10-CM Diagnosis Code C69.21Malignant neoplasm of right retina

ICD-10-CM CodesC00–D49C69-C72C69

ICD-10-CM C69.21
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C69.21 is a billable ICD-10-CM diagnosis code for malignant neoplasm of right retina. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 124 through 125. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Head and neck cancers - eye.

Code Identity

ICD-10-CM Code
C69.21
Billable Status
Yes — Valid for Submission
Code Describes
Malignant neoplasm of right retina
Short Description
Malignant neoplasm of right retina
Same as the full description in the CMS dataset.
Parent Code
Malignant neoplasm of retina

Code Classification

ChapterC00–D49Neoplasms
SectionC69-C72Malignant neoplasms of eye, brain and other parts of central nervous system
CategoryC69Malignant neoplasm of eye and adnexa
This CodeC69.21Malignant neoplasm of right retina

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Bilateral malignant melanoma of retinas
  • Malignant melanoma of left retina
  • Malignant melanoma of retina
  • Malignant melanoma of right retina
  • Primary malignant neoplasm of retina
  • Primary malignant neoplasm of right eye
  • Primary malignant neuroepithelial neoplasm of retina
  • Primary retinoblastoma of retina
  • Retinoblastoma
  • Right primary retinoblastoma
  • Right retinal primary malignant neoplasm

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO001
Head and neck cancers - eye
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • E2F1 Transcription Factor

    an e2f transcription factor that interacts directly with retinoblastoma protein and cyclin a and activates genetic transcription required for cell cycle entry and dna synthesis. e2f1 is involved in dna repair and apoptosis.
  • Genes, Retinoblastoma

    tumor suppressor genes located on human chromosome 13 in the region 13q14 and coding for a family of phosphoproteins with molecular weights ranging from 104 kda to 115 kda. one copy of the wild-type rb gene is necessary for normal retinal development. loss or inactivation of both alleles at this locus results in retinoblastoma.
  • Retinoblastoma

    a malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. the tumor tends to occur in early childhood or infancy and may be present at birth. the majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. an abnormal pupil reflex (leukokoria); nystagmus, pathologic; strabismus; and visual loss represent common clinical characteristics of this condition. (from devita et al., cancer: principles and practice of oncology, 5th ed, p2104)
  • Retinoblastoma Binding Proteins

    a family of endogenous regulatory proteins that associate with retinoblastoma protein via a specific high-affinity binding domain. members of this family of proteins are often found associated with histone-modifying enzymes and protein complexes that regulate gene expression.
  • Retinoblastoma Protein

    product of the retinoblastoma tumor suppressor gene. it is a nuclear phosphoprotein hypothesized to normally act as an inhibitor of cell proliferation. rb protein is absent in retinoblastoma cell lines. it also has been shown to form complexes with the adenovirus e1a protein, the sv40 t antigen, and the human papilloma virus e7 protein.
  • Retinoblastoma-Binding Protein 1

    a ubiquitously expressed regulatory protein that contains a retinoblastoma protein binding domain and an at-rich interactive domain. the protein may play a role in recruiting histone deacetylases to the site of retinoblastoma protein-containing transcriptional repressor complexes.
  • Retinoblastoma-Binding Protein 2

    a retinoblastoma binding protein that is also a member of the jumonji-domain histone demethylases. it has demethylation activity towards specific lysine residues found on histone h3.
  • Retinoblastoma-Binding Protein 4

    a retinoblastoma-binding protein that is involved in chromatin remodeling, histone deacetylation, and repression of genetic transcription. although initially discovered as a retinoblastoma binding protein it has an affinity for core histones and is a subunit of chromatin assembly factor-1 and polycomb repressive complex 2.
  • Retinoblastoma-Binding Protein 7

    a retinoblastoma-binding protein that has an affinity for core histones. it is found as a subunit of protein complexes that are in involved in the enzymatic modification of histones including the mi2 and sin3 histone deacetylase complexes and the polycomb repressive complex 2.
  • Retinoblastoma-Like Protein p107

    a negative regulator of the cell cycle that undergoes phosphorylation by cyclin-dependent kinases. it contains a conserved pocket region that binds e2f4 transcription factor and interacts with viral oncoproteins such as polyomavirus tumor antigens; adenovirus e1a proteins; and papillomavirus e7 proteins.
  • Retinoblastoma-Like Protein p130

    a negative regulator of the cell cycle that undergoes phosphorylation by cyclin-dependent kinases. rbl2 contains a conserved pocket region that binds e2f4 transcription factor and e2f5 transcription factor. rbl2 also interacts with viral oncoproteins such as polyomavirus tumor antigens; adenovirus e1a proteins; and papillomavirus e7 proteins.
  • Histones

    small chromosomal proteins (approx 12-20 kd) possessing an open, unfolded structure and attached to the dna in cell nuclei by ionic linkages. classification into the various types (designated histone i, histone ii, etc.) is based on the relative amounts of arginine and lysine in each.

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
retinaC69.2C79.49D09.2D31.2D48.7D49.81

Patient EducationClinical

Eye Cancer

Cancer of the eye is uncommon. It can affect the outer parts of the eye, such as the eyelid, which are made up of muscles, skin and nerves. If the cancer starts inside the eyeball it's called intraocular cancer. The most common intraocular cancers in adults are melanoma and lymphoma.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C69.21 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
190.5 Malign neopl retina
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C69.21Overview

Is C69.21 (Malignant neoplasm of retina) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of right retina on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C69.21 group to?

When malignant neoplasm of right retina is the principal diagnosis on an inpatient stay, it groups to MS-DRG 124, 125, with relative weights from 0.7678 to 1.3231 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of C69.21?

Under the General Equivalence Mappings, malignant neoplasm of right retina converts to ICD-9-CM 190.5 (malign neopl retina). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.